"This is a phenomenal opportunity for our Company to expand its loyal customer base online and reach new consumers who are looking to make knowledgeable CBD purchasing decisions," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "With the CBD market estimated by the Brightfield Group to reach $22 billion by 2022, we have a tremendous opportunity to capitalize on its current popularity and bring significant shareholder value."
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has become one of the first 21 companies to be listed on the Leafly Market, an online store with the largest selection of hemp-derived cannabidiol (CBD) products independently tested for cannabinoid potency, pesticides and heavy metals.
"We are excited and hopeful that Leafly has created a market for companies such as ourselves who want to create and sell safe, consistent CBD products that consumers can trust," said HempMeds® President Todd Morrow. "There's still a lot to be learned about the many benefits of CBD but this new platform brings another layer of confidence to the legitimacy of our products and our mission to expand access to CBD worldwide."
All products on Leafly Market have been independently tested by Leafly Certified Labs to ensure accurate CBD levels, THC levels at or below legal requirements, and freedom from dangerous levels of heavy metals and pesticides. The Leafly Market also offers consumers detailed educational content and the ability to chat with product experience experts in real-time, allowing an additional opportunity for new HempMeds® customers to learn more about its products.
"This is a phenomenal opportunity for our Company to expand its loyal customer base online and reach new consumers who are looking to make knowledgeable CBD purchasing decisions," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "With the CBD market estimated by the Brightfield Group to reach $22 billion by 2022, we have a tremendous opportunity to capitalize on its current popularity and bring significant shareholder value."
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Severity: Warning
Message: count(): Parameter must be an array or an object that implements Countable
Filename: amp/news_details_amp.php
Line Number: 252
Backtrace:
File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler
File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view
File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
media@smartmarketnews.com | sales@smartmarketnews.com
Contact Us